TATAA Biocenter has been awarded Good Laboratory Practice (GLP) accreditation. The accreditation supports the company’s strategic progression in the molecular analysis contract research organization space for advanced biopharmaceutical therapies and precision medicine.   According to the company, the demand for these services is driven by the over 2,500 cell and gene therapies being developed in the U.S. and Europe and the progress of technologies involving CRISPR, AAV vectors, and mRNA ...